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Epigenomic proﬁling of men exposed to early-life stress reveals
DNA methylation differences in association with current
mental state
B Khulan1, JR Manning1, DR Dunbar1, JR Seckl1, K Raikkonen2, JG Eriksson3,4,5,6,7 and AJ Drake1
Early-life stress (ELS) is known to be associated with an increased risk of neuropsychiatric and cardiometabolic disease in later life.
One of the potential mechanisms underpinning this is through effects on the epigenome, particularly changes in DNA methylation.
Using a well-phenotyped cohort of 83 men from the Helsinki Birth Cohort Study, who experienced ELS in the form of separation
from their parents during childhood, and a group of 83 matched controls, we performed a genome-wide analysis of DNA
methylation in peripheral blood. We found no differences in DNA methylation between men who were separated from their
families and non-separated men; however, we did identify differences in DNA methylation in association with the development of
at least mild depressive symptoms over the subsequent 5–10 years. Notably, hypomethylation was identiﬁed at a number of genes
with roles in brain development and/or function in association with depressive symptoms. Pathway analysis revealed an
enrichment of DNA methylation changes in pathways associated with development and morphogenesis, DNA and transcription
factor binding and programmed cell death. Our results support the concept that DNA methylation differences may be important in
the pathogenesis of psychiatric disease.
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INTRODUCTION
Early-life stress (ELS) is recognised as a risk factor for later mental
health disorders. Findings from a number of studies have linked
events in childhood, such as physical or sexual abuse, parental
separation, neglect or adoption, with an increased risk of
subsequent mental health disorders.1–3 The long-term adverse
effects of ELS are not limited to neuropsychiatric problems and
childhood exposure to socioeconomic disadvantage, maltreat-
ment or social isolation is also associated with an increased risk of
an adverse cardiometabolic disease risk proﬁle in adulthood.3
Longitudinal cohort studies are an invaluable resource for the
study of factors impacting on health, particularly in addressing the
long-term impact of ELS. The Helsinki Birth Cohort Study (HBCS),
comprising 13 345 individuals born in Helsinki between 1934 and
1944, is one such resource.4 During the Second World War, almost
70 000 Finnish children of varying socioeconomic status were
evacuated from their homes to temporary foster families, mainly
in the nearby countries of Sweden and Denmark. The evacuations,
which occurred between 1939 and 1944, were arranged by the
Finnish government or independently by families. Evacuations
were voluntary, but heavily promoted by the government and
particularly targeted at children living in cities. Documents on the
evacuations and their timing and length have been retained in the
Finnish National Archives’ Register. Linking evacuation data with
the HBCS has allowed the identiﬁcation of 11 028 individuals
within the HBCS who were not separated from their parents as
children, and 1719 individuals who were temporarily separated
from their parents. The average age at separation was 4.6 years (s.
d. = 2.4, range = 0.17–10.6) and the average length of separation
1.7 years (s.d. = 1.6, range = 0.05–8.1).
Previous studies in this cohort have identiﬁed a number of long-
term consequences of early-life separation. Separated individuals
have a higher prevalence of mental health disorders including
depressive symptoms and personality disorders5 and an increased
risk of substance abuse.6 The risk of any mental and substance use
disorder was highest among those with an upper childhood
socioeconomic background, perhaps suggesting increased
vulnerability.6 Separation is also associated with effects on stress
biology; separated individuals have higher average salivary
cortisol and plasma ACTH concentrations and higher salivary
cortisol reactivity to a Trier Social Stress Test.7 In men, separation
associates with poorer cognitive performance8 and with negative
effects on physical and psychosocial functioning.9 The conse-
quences of separation were not limited to effects on mental
health and the hypothalamic–pituitary–adrenal (HPA) axis, as
cohort members who were separated from their parents in
childhood also had a higher cardiovascular morbidity, including
coronary artery disease, hypertension and type 2 diabetes,10,11
with the highest prevalence of cardiovascular disease in those
who were evacuated for the longest period.11 Finally, early-life
separation also associated with differences in reproductive and
marital traits in both sexes.12
One of the potential mechanisms by which the environment in
early life might have a lasting impact on the phenotype of an
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individual is through effects on the epigenome, particularly
changes in DNA methylation13 and consistent with this, a few
studies have shown alterations in DNA methylation in association
with exposure to ELS.14,15 In this study of a unique cohort of men
in their 70s from the HBCS we have investigated the long-term
impact of early-life separation on genome-wide DNA methylation
and whether this associated with a number of clinical and
psychological variables.
MATERIALS AND METHODS
Cohort
The HBCS comprises 13 345 individuals (6370 women and 6975 men), born
as singletons between 1934 and 1944 in one of the two main maternity
hospitals in Helsinki and who were living in Finland in 1971 when a unique
personal identiﬁcation number was allocated to each member of the
Finnish population. The HBCS, which has been described in detail
elsewhere,4 has been approved by the Ethics Committee of the National
Public Health Institute. Register data were linked with permission from the
Finnish Ministry of Social Affairs and Health and the Finnish National
Archives.
In 2001–2004 at an average age of 61.5 years (s.d. = 2.9 and range= 56.7
–69.8 years), a randomly selected subsample of the cohort comprising
2003 individuals (1075 women and 928 men) was invited to a clinical
examination including collection of a blood sample for (epi)genetic and
biochemical studies and a psychological survey including a measure of
depressive symptoms. For 283 participants, extraction of DNA was not
successful, or DNA showed gender discrepancy or close relatedness. The
excluded and the included participants did not differ from each other in
any of the study variables (P-values40.13). From the remaining sample of
1720 individuals, 115 women and 97 men had been evacuated according
to the Finnish National Archives’ register. Of them nine women and 12
men had missing data on age at and length of evacuation, respectively,
and one man had missing data on father’s occupational status in
childhood. In this study, the analyses are based on 83 evacuated men
and 83 non-evacuated controls matched for sex, birth year and father’s
occupational status in childhood. For this group the mean age was 64.0
years (s.d. = 2.9) for separated and 62.9 (s.d. = 2.5) for non-separated
individuals. The mean difference in birth year is 1.21 years (P-value= 0.01)
such that evacuated individuals were born on average earlier. This reﬂects
the fact that ‘matching’ in terms of birth year was not ‘perfect’ as older
children were evacuated more frequently than younger children.
In 2009–2010 at an average age of 70.2 years (s.d. = 2.8 and range= 65.0
–76.0 years), the evacuated cases and non-evacuated controls who were
still traceable (n= 65, 78.3% and n= 63, 75.9%, respectively) were invited
for a psychological follow-up, including a re-test on depressive symptoms.
Of the evacuated cases and controls, 20 and 20 had died, their addresses
were not traceable or they had refused participation in further follow-ups,
respectively. Of them, 45 and 52 had data available on depressive
symptoms.
The clinical variables available for the cohort included age at separation,
length of separation, socioeconomic status and education level, history of
mental health disorders and a number of biological measures including
glucose, insulin, IL6, TNFα and CRP. The Beck Depression Inventory16 (BDI;
performed at the 2001–2004 clinical assessment) and the BDI II17
(performed at the 2009–2010 clinical assessment) were used to measure
the frequency of depressive symptoms. The BDI and BDI II consist of 21
items assessing symptoms of depression during the past two weeks. Each
item contains four statements reﬂecting varying degrees of symptom
severity. Respondents are instructed to circle the number that corresponds
with the statement that best describes them. Ratings are summed to
calculate a total score which can range from 0 to 63. Although the BDI and
the BDI II are designed to screen but not diagnose major depression, BDI
and BDI II cutoff scores of 10 and 14 or more, respectively, are suggestive
of mild-to-severe depressive symptoms.17–22
DNA extraction
Genomic DNA was extracted from EDTA-anti-coagulated whole peripheral
blood collected at the ﬁrst clinical assessment (2001–2004) using the
QIAamp DNA Blood Maxi Kit (Qiagen, Crawley, UK). The samples were
stored at − 20 °C before and after DNA extraction.
DNA methylation analysis
DNA methylation analysis was performed at the Genetics Core of the
Wellcome Trust Clinical Research Facility (Edinburgh, UK). Bisulphite
conversion of 500 ng input DNA was carried out using the EZ DNA
Methylation Kit (Zymo Research, Freiburg, Germany). Four microlitres of
bisulphite-converted DNA was processed using the Inﬁnium HD Assay for
Methylation. This was performed using the Illumina Methylation 450 k
beadchip and Inﬁnium chemistry (Illumina, Inc., San Diego, CA, USA). Each
sample was interrogated on the arrays against 485 000 methylation sites.
The arrays were imaged on the Illumina HiScan platform and genotypes
were called automatically using GenomeStudio Analysis software version
2011.1.
Data analysis
Data processing. Data were processed with the Lumi23 package of
Bioconductor,24 with Inﬁnium-centric routines. CpG loci were annotated
with the gene of the nearest transcription start site, as deﬁned in UCSC
hg19 and retrieved with the ‘Genomic Features’25 Bioconductor package.
Variables associated with each individual were examined independently
for association with M values of methylation using the ‘phenotest’
Bioconductor package. P-values were corrected for probe-wise multiple
testing with the Benjamini–Hochberg (BH) method. To remove any
variable associations indicated by chance, a variable was only considered
further if at least one probe passed a variable-wise Bonferroni correction.
Having removed such spurious associations, downstream analyses were
applied to values without this second correction. Individual pairwise
contrasts were then constructed from the pairs of values for all categorical
variables and examined for differential methylation using (a) linear
modelling using Limma,26 including adjustment for multiple testing and
(b) the methyAnalysis package to smooth processed data and identify
differentially methylated regions by use of t-tests applied between groups
(also BH-corrected for multiple testing).
Gene set enrichment. Gene set enrichment was analysed using annota-
tions from the Kyoto Encyclopedia of Genes and Genomes (KEGG)27 and
Gene Ontology.28 Only probes with methylation above a background of 0.2
in at least 17 (~10%) of samples were used in the enrichment background
set. Enrichment was assessed by the use of hypergeometric statistic as
implemented in the GO stats package of Bioconductor.
Genome location. To examine the genomic location of signiﬁcantly
associated loci independent of gene annotations, the genome was binned
into overlapping bins of 100 kb in size and bins with three or more
signiﬁcant loci were reported.
Validation by pyrosequencing
Pyrosequencing was used to validate DNA methylation at ﬁve CpG sites
within 200 bp of the TSS of the leucine-rich, glioma inactivated 1 (LGI1)
gene and additionally at a number of CpG sites with a spectrum of high,
low and intermediate methylation levels on the array (IL17C, SAGE1,
MIR4493, MIR548M, CLDN9 and TACC3). Bisulphite conversion was
performed on 1 μg of genomic DNA with the EZ DNA methylation kit
(Zymo Research). The converted DNA was ampliﬁed using the AmpliTaq
Gold 360 kit (Applied Biosystems, Warrington, UK) with primers mapping
to target regions containing CpGs assayed within the array. PCR primers
(Supplementary Table 1) were designed using PyroMark Assay Design
Software 2.0 (Qiagen). Pyrosequencing was performed using PyroMark
Q24Gold reagents on a PyroMark Q24 Pyrosequencer (Qiagen) according
to the manufacturer’s instructions. Data were extracted and analysed using
PyroMark Q24 1.0.10 software (Qiagen). Background non-conversion levels
were o3%.
RESULTS
Association of methylation with clinical variables
Principal components analysis showed no clear clusters and no
obvious differences between the way separated and non-
separated individuals or different socioeconomic groupings
clustered. Linear modelling between clinical variables and
methylation showed no associations between DNA methylation
and most clinical variables including separation status and
socioeconomic status. There were signiﬁcant associations
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between DNA methylation in peripheral blood taken at the ﬁrst
clinical assessment (2001–2004) and categorical scores on the BDI
II performed at the second assessment some years later (Table 1).
When speciﬁc contrasts in categorical variables were queried
using linear modelling, differential methylation was identiﬁed at
474 probes representing 445 genes, all of which associated with
the clinical cutoffs indicative of at least mild depressive symptoms
on the BDI II (representing a score of 14–25; Table 1 and
Supplementary Table 2). This contrast involves a relatively small
number of eight individuals, compared to 88 individuals with
minimal depressive symptomatology (a score of 1–13). Running
methyAnalysis with its associated smoothing produced a larger
number of signiﬁcant probes (491 probes representing 351 genes;
Table 1), again predominantly in association with BDI II categorical
score indicative of at least mild depressive symptoms. Of these, 80
genes showed differential methylation at more than one probe.
There were 170 of the signiﬁcant probes and 175 associated genes
present in the lists from both methods. MethyAnalysis results were
used in subsequent analyses.
For genes, which had methylation changes observed in the
same direction for more than one CpG site, DNA methylation was
decreased in ~ 2/3 and increased in ~ 1/3 in association with a BDI
II score indicative of at least mild symptomatology (Table 1).
Differential methylation in association with a BDI II score indicative
of mild depressive symptoms was identiﬁed at a number of genes
with possible roles in brain development and/or function (Table 2),
all of which showed hypomethylation (Figure 1). Among the most
well-supported genes in terms of multiple signiﬁcant probes were
LGI1 and LGI2 which are thought to have important roles in brain
development and function.29,30 Hypomethylation was present at
ﬁve probes within the promoter of LGI1,31 and at three probes in a
CpG island shore close to LGI2. Overall, signiﬁcant loci were more
likely to be identiﬁed in CpG island shores rather than in CpG
islands or at the TSS (χ2 P-value = 6× 10−8; Supplementary Table 3),
in agreement with the data from a study in postmortem brains.32
A number of 100 Kb bins in the genome contained three or more
signiﬁcant loci in the output from methyAnalysis associated with
Beck Depression Questionnaire (Table 3).
Pathway analysis
Analysis of gene ontology for the genes associated with altered
DNA methylation and BDI II score using the molecular function,
cellular component and biological processes categories of the
Gene Ontology database28 revealed enrichment of a number of
gene ontology terms, particularly within the molecular function
and biological processes categories (Table 4). Mean methylation
was decreased for all the genes within enriched pathways. The set
of overrepresented categories included a signiﬁcant number
associated with development and morphogenesis, and DNA and
transcription factor binding. In addition, consistent with the
ﬁndings of a recent study in postmortem brain from individuals
with depression compared with individuals without, a number of
the identiﬁed gene sets are involved in programmed cell death;32
notably, hypomethylation was also found in association with
depression in this study.
Array validation
To validate the array ﬁndings, pyrosequencing was performed to
conﬁrm the ﬁndings at LGI1 and additionally for a number of
genes which had low, high or intermediate methylation levels.
DNA methylation levels at the ﬁve CpG sites within the promoter
of LGI1 were highly correlated with each other (r= 0.68–0.98;
Po0.01) and highly signiﬁcant correlations between array and
pyrosequencing data were conﬁrmed for all ﬁve CpGs (r= 0.86-
–0.97; all Po0.0001). Signiﬁcant correlations were also conﬁrmed
for probes located in IL17C, SAGE1, MIR4493 and MIR548M (r
ranging from 0.28–0.97, all Po0.05. Combining all loci: r= 0.9770;
Po0.0001). Although no correlations were observed between the
array and pyrosequencing for CLDN9 and TACC3, this is not
surprising as pyrosequencing analysis revealed that DNA methyla-
tion levels were o5% at these loci, which is below the reliable
limit of detection.
LGI1 NTSR2 LGI2 SLC25A12 TP73 TSKU APOC1 DRAXIN PURA
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Figure 1. Differential methylation in association with Beck Depression Inventory II (BDI II) score. Hypomethylation was present at multiple
probes corresponding to genes with possible roles in brain development and/or function. BDI II= 1 indicates a score of 1–13, that is, minimal
symptomatology; BDI II= 2 indicates a score of 14–25, that is, at least mild symptomatology.
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DISCUSSION
Studies in animal models have shown a signiﬁcant inﬂuence of
early-life adversity on behaviour and stress axis responsiveness
(reviewed in ref. 44). ELS in rodents is associated with effects on
DNA methylation in the brain in both candidate gene45–47 and
genome-wide studies.48 In humans, genome-wide methylation
proﬁling of hippocampal tissue from suicide victims has revealed
that experience of abuse during childhood is associated with
altered DNA methylation at multiple gene promoters.49 Impor-
tantly, and perhaps not surprisingly given that the long-term
effects of ELS are seen in multiple systems, changes in DNA
methylation have also been reported in cells which are more
accessible for large studies in human populations, for example,
lymphocytes and buccal cells. Altered DNA methylation has been
found in DNA from buccal cells from adolescents whose parents
reported experiencing high levels of stress during their children’s
early years50 and a recent small study in children showed
differences in DNA methylation in peripheral blood between
children raised by their parents and children who had been
institutionalized.51 Furthermore, candidate gene studies in per-
ipheral blood DNA have identiﬁed associations between ELS and
DNA methylation at the glucocorticoid receptor52–55 and the
serotonin transporter.56–58 Nevertheless, not all studies report
differences in DNA methylation as a consequence of ELS, for
example, Smith et al.59 found no association between child abuse
and global or gene-speciﬁc DNA methylation in peripheral blood
from African-American adults.
Although the deleterious effects of separation in infancy and
childhood persist throughout life, so that more than 60 years later,
those who were evacuated in infancy/childhood, when compared
with non-evacuated individuals, display over 20% higher levels of
depressive symptoms,5 a more than twofold higher risk of
cardiovascular morbidity and a 1.4-fold in type 2 diabetes risk,11
we did not identify differences in DNA methylation between men
who were separated from their families compared with men who
remained with their families. In addition, although several studies
have reported associations between early-life socioeconomic
status and DNA methylation in adulthood,60,61 we found no
evidence for this in these men from the HBCS. This is one of the
largest studies of genome-wide methylation in the context of ELS
and the individuals participating in the study have been extremely
well phenotyped. The men studied here were not selected on the
basis of current mental health status and although other studies
have reported small differences in DNA methylation at candidate
genes in otherwise healthy adults with a reported history of
ELS,56,57 others have reported effects of ELS on DNA methylation
speciﬁcally in the context of ongoing mental health disorders,52,62
so that this may be one explanation for the lack of any association
between ELS and DNA methylation in the HBCS.
Table 3. 100 Kb bins in the genome containing three or more signiﬁcant loci in the output from methyAnalysis associated with Beck Depression
Questionnaire
Chr Bin start (Mb) Count Probes Genes
chr11 76.30 8 cg01048195, cg01439670, cg05076755, cg07202214, cg10788371, cg13633560, cg13985437,
cg20533899
LRRC32, TSKU
chr1 40.70 7 cg04100190, cg12733396, cg14844588, cg18186394, cg23847109, cg26011014, cg26710722 COL9A2
chr3 170.70 6 cg01146875, cg03699904, cg07139301, cg14777768, cg24302235, cg25203962 SLC2A2
chr1 236.50 5 cg00178850, cg04311403, cg09164898, cg15202123, cg15677293 LGALS8
chr10 95.50 5 cg06833709, cg07793207, cg13763783, cg13858227, cg13928759 LGI1
chr11 76.80 5 cg01858879, cg02420069, cg03991848, cg08294946, cg17441778 MYO7A
chr16 88.90 5 cg04996089, cg07716131, cg08144157, cg22728782, cg27483694 PABPN1L
chr16 3.10 5 cg02532518, cg04635334, cg05226462, cg08289130, cg13928306 OR1F1, ZNF205
chr3 148.80 5 cg03678609, cg04731810, cg05555455, cg21111416, cg27554556 HPS3
chr4 147.10 5 cg01539483, cg04181032, cg07701757, cg07973709, cg23381863 LOC100505545
chr6 26.20 5 cg00436476, cg00620190, cg05159188, cg12260798, cg22723502 HIST1H4F
chr10 135.20 4 cg02114346, cg14353649, cg16692735, cg20534287 PAOX, LOC619207
chr13 112.70 4 cg03898631, cg12187394, cg15736169, cg24747764 SPACA7
chr17 1.30 4 cg03149719, cg06967127, cg09594075, cg22021934 PITPNA-AS1
chr2 11.90 4 cg15374751, cg15614119, cg23689227, cg25654774 NTSR2
chrY 21.70 4 cg05621349, cg07731488, cg10076560, cg15682993 TXLNG2P, BCORP1
chr1 3.60 3 cg00589002, cg04159546, cg23052055 TP73
chr1 6.50 3 cg07181374, cg22451657, cg24332389 PLEKHG5
chr1 45.20 3 cg03043406, cg04008821, cg07368443 SNORD38A, PLK3
chr10 135.10 3 cg02114346, cg14353649, cg20534287 PAOX
chr11 44.30 3 cg06962549, cg13837679, cg17017404 CD82
chr11 115.50 3 cg06717905, cg08019736, cg10752604 CADM1
chr14 74.70 3 cg09816693, cg11176135, cg14855607 VSX2, VRTN
chr14 80.60 3 cg00217795, cg14471244, cg14975009 DIO2-AS1
chr15 77.90 3 cg07808023, cg13834146, cg25861169 LOC253044
chr16 3.20 3 cg02532518, cg04635334, cg08289130 OR1F1
chr17 35.40 3 cg13095450, cg15906733, cg25821249 C17orf78
chr17 38.40 3 cg04173528, cg19291926, cg23188547 CDC6
chr19 57.90 3 cg00415822, cg20243078, cg26941891 ZNF419
chr2 121.10 3 cg00421221, cg04065338, cg21840697 TMEM185B, INHBB
chr2 172.90 3 cg04522045, cg13433278, cg16573755 SLC25A12
chr21 44.40 3 cg02644491, cg14171527, cg19312314 CRYAA
chr4 25.00 3 cg05844193, cg22366375, cg27177983 LGI2
chr6 30.40 3 cg11594821, cg13007871, cg21758773 PRR3
chr6 41.40 3 cg05234552, cg08655662, cg20263901 FOXP4
chr6 132.20 3 cg14623917, cg22843613, cg24684168 LOC100507254
chr7 129.40 3 cg14794735, cg18892485, cg22047901 MIR183
Associated genes are those with transcriptional start sites closest to the CpGs in question.
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We did identify differences in DNA methylation at a number of
genes in association with the development of at least mild
depressive symptomatology over the subsequent 5–10 years.
Differential methylation in association with a BDI II score indicative
of mild depressive symptoms was identiﬁed at a number of genes
with possible roles in brain development and function, all of which
showed hypomethylation, consistent with recent studies in brain
tissue from individuals with depression, although the mechanisms
accounting for this loss of methylation is not clear.32 Notably,
differential methylation was noted at a number of CpGs within the
promoter of LGI1, a gene associated with epilepsy and psychiatric
disorders.30 LGI1 appears to function in the synapse and has
important roles in brain development and function, including in
the regulation of postsynaptic function during development, in
dendritic pruning and in the maturation of pre- and postsynaptic
membrane functions of glutamatergic synapses during postnatal
development.29,30 Differential methylation was also noted near
the gene encoding LGI2; intriguingly, differential methylation at
LGI2 has previously been identiﬁed in association with major
depressive disorder (MDD).36
Consistent with studies showing alterations in DNA methylation
in postmortem brain or blood of individuals with MDD, major
psychosis and posttraumatic stress disorder, the observed
differences in DNA methylation in our study were small (generally
o10%).36,62–64 Three recent studies have analysed DNA methyla-
tion in individuals with MDD compared with a control
population.32,36,65 Using DNA from peripheral blood Byrne
et al.65 found no signiﬁcant methylation differences between
twins discordant for MDD although the twins with MDD showed
increased variation in methylation across the genome. Another
slightly larger study identiﬁed DNA methylation differences at 224
candidate regions, which were highly enriched for neuronal
growth and development genes in DNA from frontal cortex
collected from postmortem brains.36 While the differentially
methylated gene regions identiﬁed in brain in the latter study
showed little overlap with those identiﬁed in the HBCS, analysis of
gene ontology identiﬁed an overrepresentation of developmental
pathways in both studies, suggesting potential common mechan-
isms in the pathogenesis of depression.
There are tissue-speciﬁc differences in DNA methylation
proﬁles, which are likely to reﬂect cellular identity and tissue
function,66,67 so that it is difﬁcult to infer causality from studies
performed on DNA from peripheral blood with respect to
conditions primarily affecting other organs. For studies in the
brain, this is further complicated by differences in DNA methyla-
tion across different brain regions, which may be one explanation
for the disparities between studies.68 Detailed studies of different
regions of the brain in speciﬁc disease states are needed to
identify additional and/or more subtle epigenetic changes which
may be particularly pertinent to particular phenotypes and which
can be related to gene expression and function in the region of
interest.49,63 Nevertheless, as data from an increasing number of
studies suggest that some disease-relevant epigenetic changes
are conserved across different tissues,64,69–72 the ﬁndings from
studies using accessible tissues such as blood may indeed give
important insights into disease pathogenesis and lead to the
development of new biomarkers which can be utilized in
population studies.
In conclusion, although we were unable to identify differences
in DNA methylation as a consequence of early-life separation in a
large study of well-phenotyped men from the HBCS, methylation
differences were identiﬁed in peripheral blood in association with
the ﬁnding of depressive symptoms some 5–10 years later.
Although the numbers of men with at least mild depressive
symptoms was small compared with those without, the numbers
are comparable to other studies of this nature in individuals with
psychiatric disorders.32,64,65 Our study involved only a cohort of
well-studied men, closely matched for a number of factors
including age, for whom longitudinal data were available and
such prospective cohort studies have been highlighted as being of
particular importance in improving the understanding of the role
of age-related epigenetic changes in the development of
disease;73 further studies will be necessary to study any similar
effects in women. The ﬁndings of hypomethylation in association
with the subsequent development of depressive symptoms, and
the identiﬁcation of common pathways and candidate genes are
in agreement with other studies. Our results support the concept
that DNA methylation differences may be important in the
pathogenesis of psychiatric disease and raise the intriguing
possibility that changes in DNA methylation may be predictive
of the development of depression.
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